Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.
Nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) is required for the conversion of extracellular ATP into inorganic pyrophosphate (PP(i)), a recognised inhibitor of hydroxyapatite (HA) crystal formation. A detailed phenotypic assessment of a mouse model lacking NPP1 (Enpp1(-/-)) was completed t...
Saved in:
| Main Authors: | Neil Charles Wallace Mackenzie, Dongxing Zhu, Elspeth M Milne, Rob van 't Hof, Aline Martin, Leigh Darryl Quarles, José Luis Millán, Colin Farquharson, Vicky Elisabeth MacRae |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0032177&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.
by: Dongxing Zhu, et al.
Published: (2011-01-01) -
FGF23 Producing Mesenchymal Tumor
by: Lucyna Papierska, et al.
Published: (2014-01-01) -
Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01) -
Tumor-Induced Osteomalacia in a Patient With FGF23-Amplified Lung Adenocarcinoma and FGF23-Deleted SCLC: Case Report
by: Marcello Moro Queiroz, MD, et al.
Published: (2025-06-01) -
A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression
by: Jason R Baird, et al.
Published: (2024-12-01)